Genetic testing for chemotherapy in non-small cell lung cancer
- 1 August 2003
- journal article
- review article
- Published by Elsevier BV in Lung Cancer
- Vol. 41, 97-102
- https://doi.org/10.1016/s0169-5002(03)00151-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trialAnnals Of Oncology, 2002
- An Analysis of DNA Repair as a Determinant of Survival in Patients With Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumorsCancer Letters, 2001
- ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil ChemotherapyJournal of Clinical Oncology, 2001
- P53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblastsOncogene, 2001
- Proneness to UV-induced apoptosis in human fibroblasts defective in transcription coupled repair is associated with the lack of Mdm2 transactivationOncogene, 2000
- DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapyInternational Journal of Cancer, 2000
- Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosisOncogene, 1998
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992